The CDC announced it will screen for the emerging coronavirus from China in 3 US airports; the US birth rate is at an all-time low; tech giants strike deals with hospitals to access millions of medical records.
The CDC announced last Friday that it is deploying more than 100 staffers to 3 US airports to check passengers arriving from Wuhan, China, for fever and other symptoms of the new virus, 2019 Novel Coronavirus, according to CNN. The most recent previous routine passenger health screening was during the Ebola crisis in 2014. John F. Kennedy International, San Francisco International, and Los Angeles International airports are the 3 sites where the screenings will take place. They were chosen because most passengers who flew from Wuhan to the United States entered through these airports. The symptons being screened for include coughing, difficulty breathing, and temperature. Three cases of 2019 Novel Coronavirus have been reported in Thailand and Japan.
According to data from the National Vital Statistics System, the US fertility rate is at an all-time low of 1.73 births per mother. The Washington Post reports that the current fertility rate is below what is considered the replacement rate, which is producing as many births each year as deaths. While the report did not cite causes of the birth rate reduction, other data showed that women are having children later in life, with fewer births occurring between the teen years to early 30s and more births from ages 35 to 44.
Hospitals have granted tech giants such as Microsoft, International Business Machines, and Amazon, access to identifiable patient information through deals amounting to millions of health records, according to The Wall Street Journal. The deals serve as the latest example of hospitals’ emerging influence in the data economy, with fellow tech giant Google similarly seeking access to patient data. One prominent example is health-data company Cerner Corp being offered close to $250 million in incentives from Google.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Untangling Medical Debt From Credit Scores: Effects So Far and Next Steps
November 29th 2023After recent policy changes removing most medical debts from credit reports, Americans are seeing their credit scores increase, but experts warn of the need to monitor billing and collection practices for unintended consequences.
Read More
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Untangling Medical Debt From Credit Scores: Effects So Far and Next Steps
November 29th 2023After recent policy changes removing most medical debts from credit reports, Americans are seeing their credit scores increase, but experts warn of the need to monitor billing and collection practices for unintended consequences.
Read More
2 Clarke Drive
Cranbury, NJ 08512